Literature DB >> 25482510

Functional splicing network reveals extensive regulatory potential of the core spliceosomal machinery.

Panagiotis Papasaikas1, J Ramón Tejedor1, Luisa Vigevani1, Juan Valcárcel2.   

Abstract

Pre-mRNA splicing relies on the poorly understood dynamic interplay between >150 protein components of the spliceosome. The steps at which splicing can be regulated remain largely unknown. We systematically analyzed the effect of knocking down the components of the splicing machinery on alternative splicing events relevant for cell proliferation and apoptosis and used this information to reconstruct a network of functional interactions. The network accurately captures known physical and functional associations and identifies new ones, revealing remarkable regulatory potential of core spliceosomal components, related to the order and duration of their recruitment during spliceosome assembly. In contrast with standard models of regulation at early steps of splice site recognition, factors involved in catalytic activation of the spliceosome display regulatory properties. The network also sheds light on the antagonism between hnRNP C and U2AF, and on targets of antitumor drugs, and can be widely used to identify mechanisms of splicing regulation.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25482510     DOI: 10.1016/j.molcel.2014.10.030

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  81 in total

Review 1.  The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches.

Authors:  Elisabeth Daguenet; Gwendal Dujardin; Juan Valcárcel
Journal:  EMBO Rep       Date:  2015-11-13       Impact factor: 8.807

Review 2.  MECHANISMS IN ENDOCRINOLOGY: Alternative splicing: the new frontier in diabetes research.

Authors:  Jonàs Juan-Mateu; Olatz Villate; Décio L Eizirik
Journal:  Eur J Endocrinol       Date:  2015-12-01       Impact factor: 6.664

3.  The spliceosome assembly factor GEMIN2 attenuates the effects of temperature on alternative splicing and circadian rhythms.

Authors:  Rubén Gustavo Schlaen; Estefanía Mancini; Sabrina Elena Sanchez; Soledad Perez-Santángelo; Matías L Rugnone; Craig G Simpson; John W S Brown; Xu Zhang; Ariel Chernomoretz; Marcelo J Yanovsky
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

4.  Deubiquitinase USP47-stabilized splicing factor IK regulates the splicing of ATM pre-mRNA.

Authors:  Hye In Ka; Sunyi Lee; Sora Han; Ae Lee Jeong; Ji Young Park; Hyun Jeong Joo; Su Jung Soh; Doyeon Park; Young Yang
Journal:  Cell Death Discov       Date:  2020-05-04

5.  The Output of Protein-Coding Genes Shifts to Circular RNAs When the Pre-mRNA Processing Machinery Is Limiting.

Authors:  Dongming Liang; Deirdre C Tatomer; Zheng Luo; Huang Wu; Li Yang; Ling-Ling Chen; Sara Cherry; Jeremy E Wilusz
Journal:  Mol Cell       Date:  2017-11-22       Impact factor: 17.970

Review 6.  Iron and Cancer.

Authors:  Suzy V Torti; David H Manz; Bibbin T Paul; Nicole Blanchette-Farra; Frank M Torti
Journal:  Annu Rev Nutr       Date:  2018-08-21       Impact factor: 11.848

7.  Identification of RNA-binding domains of RNA-binding proteins in cultured cells on a system-wide scale with RBDmap.

Authors:  Alfredo Castello; Christian K Frese; Bernd Fischer; Aino I Järvelin; Rastislav Horos; Anne-Marie Alleaume; Sophia Foehr; Tomaz Curk; Jeroen Krijgsveld; Matthias W Hentze
Journal:  Nat Protoc       Date:  2017-11-02       Impact factor: 13.491

Review 8.  Modulating splicing with small molecular inhibitors of the spliceosome.

Authors:  Kerstin A Effenberger; Veronica K Urabe; Melissa S Jurica
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-07-21       Impact factor: 9.957

Review 9.  RNA mis-splicing in disease.

Authors:  Marina M Scotti; Maurice S Swanson
Journal:  Nat Rev Genet       Date:  2015-11-23       Impact factor: 53.242

Review 10.  Biology of the mRNA Splicing Machinery and Its Dysregulation in Cancer Providing Therapeutic Opportunities.

Authors:  Maxime Blijlevens; Jing Li; Victor W van Beusechem
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.